Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 7/20 | 0.56 |
| ▸ | CNR2 | P34972 | 6/20 | 0.56 |
| ▸ | CREBBP | Q92793 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3990809 | 0.86 | CNR2 (0.60) | CNR1CNR2 | |
| SCHEMBL3995883 | 0.86 | CNR2 (0.55) | CNR1CNR2TSHRL3MBTL1MAPT | |
| SCHEMBL3973488 | 0.84 | NR4A2 (0.51) | CNR1CNR2L3MBTL1SMN1; SMN2LMNA | |
| SCHEMBL3980644 | 0.82 | ALDH1A1 (0.48) | CNR1CNR2GAATSHRL3MBTL1 | |
| SCHEMBL13806412 | 0.82 | CNR2 (0.47) | CNR1CNR2SMN1; SMN2 | |
| SCHEMBL3990432 | 0.80 | CNR2 (0.53) | CNR1CNR2 | |
| SCHEMBL3972624 | 0.80 | POLB (0.55) | MAPTSMN1; SMN2LMNAPOLB | |
| SCHEMBL3986991 | 0.79 | CNR2 (0.47) | CNR1CNR2 | |
| SCHEMBL3995341 | 0.78 | CNR2 (0.48) | CNR1CNR2 | |
| SCHEMBL3993924 | 0.77 | CNR2 (0.57) | CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2065382-A1 | CGRP antagonists | Boehringer Ingelheim Pharma GmbH & Co. KG (DE) | 2009-06-03 | — | — | EP | disclosed |
| WO-2009050235-A1 | CGRP ANTAGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-04-23 | — | — | WO | disclosed |